Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.
about
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst FacetHypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaDownregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells.EMT and inflammation: inseparable actors of cancer progression.New insights into the role of EMT in tumor immune escape.The multifaceted role of autophagy in tumor evasion from immune surveillanceMechanism of immune evasion in breast cancer.Role of tumor microenvironment in tumorigenesis.Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3.EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.Role of interleukin-6 in cancer progression and therapeutic resistance.Naproxen Inhibits UVB-induced Basal Cell and Squamous Cell Carcinoma Development in Ptch1+/- /SKH-1 Hairless Mice.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?EMT in immuno-resistance.Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity.Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review).Placental Growth Factor Triggers Epithelial-to-Mesenchymal Transition-like Changes in Rat Type II Alveolar Epithelial Cells: Activation of Nuclear Factor κB Signalling Pathway.Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells.Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance.p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations.MicroRNAs in regulation of triple-negative breast cancer progressionMacrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonizationHigh expression of S100A12 on intratumoral stroma cells indicates poor prognosis following surgical resection of hepatocellular carcinoma
P2860
Q26746478-FDD1B7E7-55C0-4354-B6A1-6EEE66B33AA3Q28079816-3E43EA39-C240-4891-B7F9-8A2F9325A07AQ28085029-97BB0E35-DDDA-48B3-B8B9-0C8DB0D3EF65Q33765984-BDD0A0B2-43D2-4A6B-9AC8-F67AEAB2C986Q33869755-4FC2B1EC-7850-4A1A-BAE6-D12C964572D0Q33869781-4492795D-D050-4B90-A3E4-AE71EA4D204CQ37109549-A2F1C282-E8CF-46AC-9049-0FF3C28D9038Q37712385-D640B231-F983-49D2-BBB1-F55BEFDD827AQ37738074-A7BECB23-6110-4F70-8D48-796CEEC80717Q38619063-712CA1A3-CA1D-45F2-AC96-5C2F9E203445Q38677439-ECA0921F-F46C-4546-BD96-34BA9346BCB3Q38720963-252579CA-34D3-4F2F-8C8F-6FB0F47EDC58Q38736999-E4D4729D-5BDF-43AA-BCA6-4FAD8326AAB9Q38853625-43A4A5B8-B752-4DD1-A130-03BB941B8B9FQ38886252-35A0B483-3483-42F9-90BE-10B3FE4D4296Q41928232-D5CDBAD6-D54B-48FC-9CF5-509B25AC71B6Q43141024-8CBE0EEF-D0FB-4499-BC52-0E2291D1358CQ47120916-00B8D6D1-6B5A-4705-BEA3-B96618F14092Q47708680-880F9F63-4CA6-4447-AE9F-A0F67641D3F2Q47852274-5E1E04EF-D126-496F-9DA3-3BEF5DB62A65Q48162761-2469A16E-23F5-4B66-A660-3A0170DF27C6Q49243761-D9AC85C5-0263-4134-9E98-880C51FF53A1Q49501076-8B03AD9B-A054-47ED-8E76-502CBB4F7A2AQ53611300-2F5F5283-C446-4182-A01B-D38334B4C580Q54936001-C0767BB8-86EE-4F73-B37B-1C97725540DBQ54986341-8ED040A8-0A35-437B-A0A5-FA3BB4802A89Q55480165-C4B12875-D5F1-436D-8AD0-4C3FB430FE8FQ55515332-E3D776A4-AD09-48D6-98A1-A83A3D7918C5Q57111303-47253F59-856C-413E-981A-0C7CC4355D8DQ58740853-E4C7ECD0-879E-49D1-94FA-F371E805B325Q58798310-1A9C312C-24BA-46AF-98E5-98294FD6DC19
P2860
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Epithelial-to-mesenchymal tran ...... ry properties in cancer cells.
@en
type
label
Epithelial-to-mesenchymal tran ...... ry properties in cancer cells.
@en
prefLabel
Epithelial-to-mesenchymal tran ...... ry properties in cancer cells.
@en
P2093
P2860
P50
P356
P1476
Epithelial-to-mesenchymal tran ...... ory properties in cancer cells
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2015.29
P407
P577
2015-03-17T00:00:00Z
P5875
P6179
1024037001